| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |